Medline Inc. Class A common stock earnings per share and revenue
On --, MDLN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of 0.24 USD, with revenue projected to reach 7.66 billion USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
FAQ
What were Medline Inc. Class A common stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Medline Inc. Class A common stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Medline Inc. Class A common stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Medline Inc. Class A common stock expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Medline Inc. Class A common stock's next earnings report?
Based on --
analysts, Medline Inc. Class A common stock is expected to report EPS of $0.24 and revenue of $7.66B for Q4 2025.